One drug called spironolactone, often used to treat high blood pressure, has shown promise in protecting the kidneys of ...

Renalytix plc (LSE: RENX) (OTCQB: RNLXY), today announced an agreement with Tempus AI, Inc. (NASDAQ: TEM) to make ...

When you have uncontrolled blood sugar, it can affect your health in several ways. High blood sugar levels damage different ...

New research has revealed exciting news for people with type 2 diabetes and chronic kidney disease. A medication called ...

Severe hypoglycemia is linked to a higher rate of retinopathy in patients with type 2 diabetes and proliferative disease in ...

Prediabetes affects nearly 25 million Indians and often goes unnoticed. Learn about symptoms, risk factors, tests, and ...

Kidney disease is becoming a growing problem in developing countries, caused by an explosion in cases of diabetes and high blood pressure, experts say. As developing countries become increasingly ...

A gut microbe molecule drives diabetic kidney scarring. Blocking it may offer new treatment options. A new study from the ...

New research has revealed that there is a medicine that not only controls diabetes but can also give new hope to patients by ...

Under the agreement, Tempus and Renalytix will work with US healthcare systems to make the KidneyintelX.dkd test more available to order within existing clinical workflows.

Nine out of 10 people with chronic kidney disease only find out when it progresses to later stages. Here’s what we know about ...

Across the globe, roughly 44 percent of people with diabetes dont know they have it. In the United States, about 17 percent ...